Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.02.729654

Cross Potential Selection for Multiple Traits Considering the Progeny Distribution of Future Inbred Lines in Plant Breeding Programs

Abstract

In plant breeding, it is often necessary to improve a target trait while maintaining other essential traits within desirable ranges. When genetic relationships exist among these traits, improvements in the target trait may lead to undesirable changes in essential traits, complicating cross selections. In such cases, it is critical to select cross-pairs that are expected to produce progeny that satisfy the requirements for all traits. The progeny distribution of each crossing pair can be predicted using the estimated genotypic values and genetic (co)variances of the target and essential traits. By utilizing this distribution, the probability of generating progeny that satisfy predefined trait requirements can be evaluated, allowing a direct comparison of alternative crosses. In this study, we developed Cross Potential Selection for Multiple Traits (CPS-MT), a breeding strategy designed to improve a target trait while maintaining one or more essential traits within desirable ranges. CPS-MT extends the original Cross Potential Selection (CPS) framework to explicitly handle trade-offs between traits under genetic correlations. We evaluated the performance of CPS-MT through simulations involving four types of genetic relationships and two genetic causal factors between traits, resulting in seven scenarios. Across all scenarios, CPS-MT consistently improved the likelihood of obtaining desirable progeny, indicating that CPS-MT provides a practical and effective framework for cross selection under multi-trait constraints in breeding programs. Article SummaryThis study developed Cross Potential Selection for Multiple Traits (CPS-MT), a new breeding strategy designed to improve a target trait while maintaining one or more essential traits within desirable ranges. CPS-MT evaluates crossing pairs by predicting progeny distributions based on estimated genotypic values and genetic covariances, enabling direct comparison of alternative crosses under multi-trait constraints. Through simulations incorporating four types of genetic relationships and two causal factors (seven scenarios), CPS-MT consistently increased the likelihood of obtaining progeny that satisfied the predefined trait requirement. These results indicate that CPS-MT provides a practical, robust framework for target trait improvement under trait constraints.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sakurai, K., Moreau, L., Mary-Huard, T., Charcosset, A., Iwata, H.. 2026-06-08. Cross Potential Selection for Multiple Traits Considering the Progeny Distribution of Future Inbred Lines in Plant Breeding Programs. https://doi.org/10.64898/2026.06.02.729654

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗